EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Functional Heterogeneity of Hepatitis B Virus-Specific CD8+ T Cells Mediates the Clinical Outcomes of Infection

Zhijun Shen, Xin Wang, Juan Zhao, Mi Wu, Ting Zhou, Lichen Ouyang, Xiufang Weng, Shiguo Liu, Xiongwen Wu

Frontiers in Bioscience-Landmark · 21.05.2026 · 31 (5)

DOI: 10.31083/fbl51459 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Bioscience-Landmark, online erschienen am 21.05.2026. Verfasst von Zhijun Shen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, 430030 Wuhan, Hubei, China. Hauptthemen laut MEDLINE: Hepatitis B virus, CD8-Positive T-Lymphocytes. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation, China, Research Foundation of the Health Commission of Hubei Province Scientific Research Project, China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hepatitis B virus (HBV)-specific CD8+ T cells play a crucial role in viral clearance. However, in patients with chronic hepatitis B infections, sustained immune activation leads to functional impairment of these HBV-specific CD8+ T cells. The goal of this study was to clarify whether these virus-specific CD8+ T cells are exhausted or reflect an incomplete response derived from the initial T cell repertoire.

Methods

In this study, HBV core 18–27 epitope-specific CD8+ T cells were identified by proliferation through in vitro antigen stimulation. Peptide-specific CD8+ T cells recognizing the cytomegalovirus (CMV) pp65 495–503 epitope were used as a positive control, as they exhibit a robust immune response. Single-cell sequencing was employed to characterize the TCR repertoire of expanded clones. Correlations between T cell subsets and clinical outcomes were analyzed and compared.

Results

Both HBV core 18–27-specific and CMV pp65-specific CD8+ T cells were successfully classified into three functionally distinct subsets: IFNγ+, mTGFβ+, and IFNγ–/mTGFβ–. Those patients with resolved acute HBV infections and HBV core 18–27 specific CD8+ T cells exhibited the highest IFNγ+/mTGFβ+ ratio, reaching levels comparable to those of CMV pp65-specific CD8+ T cells. Inactive HBV carriers exhibited the second-highest IFNγ+/mTGFβ+ ratio, while this ratio was lowest among patients exhibiting viral immune tolerance. HBV core 18–27 tetramer staining and ERGO-Ⅱ Model prediction demonstrated that IFNγ+ subset CD8+ T cells exhibited the highest affinity for this epitope, followed by the mTGFβ+ subset, with IFNγ–/mTGFβ– cells exhibiting the lowest affinity.

Conclusions

These results suggest that individuals with a high IFNγ+/mTGFβ+ ratio exhibit a lower HBV viral load. The IFNγ+/mTGFβ+ CD8+ T cell ratio, in particular, appears to be associated with HBV clearance, and this may be attributable to T cell receptor affinity for HBV epitopes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis B virusCD8-Positive T-LymphocytesHumansEpitopes, T-LymphocyteT-Cell ExhaustionHepatitis B, Chronic

Stichwörter der Autor:innen

CD8-Positive T-LymphocytesT-cell receptor diversityTCR affinitycell proliferationchronic hepatitis Bimmune toleranceligand-receptor interactionsviral load

Substanzen

Epitopes, T-Lymphocyte

Autor:innen und Institutionen

  • Department of Immunology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, 430030 Wuhan, Hubei, China.
  • Department of Clinical Laboratory, Hubei No.3 People's Hospital of Jianghan University, 430033 Wuhan, Hubei, China.
  • Department of Immunology, School of Medicine, Jianghan University, 430056 Wuhan, Hubei, China.

Förderung

  • National Natural Science Foundation, China
  • Research Foundation of the Health Commission of Hubei Province Scientific Research Project, China

Zitieren

APA

Shen, Z., Wang, X., Zhao, J., Wu, M., Zhou, T., Ouyang, L., Weng, X., Liu, S., & Wu, X. (2026). Functional Heterogeneity of Hepatitis B Virus-Specific CD8+ T Cells Mediates the Clinical Outcomes of Infection. Frontiers in Bioscience-Landmark, 31(5). https://doi.org/10.31083/fbl51459

Vancouver

Shen Z, Wang X, Zhao J, Wu M, Zhou T, Ouyang L, et al. Functional Heterogeneity of Hepatitis B Virus-Specific CD8+ T Cells Mediates the Clinical Outcomes of Infection. Frontiers in Bioscience-Landmark. 2026;31(5). doi:10.31083/fbl51459

BibTeX
@article{Shen2026,
  author = {Shen, Zhijun and Wang, Xin and Zhao, Juan and Wu, Mi and Zhou, Ting and Ouyang, Lichen and Weng, Xiufang and Liu, Shiguo and Wu, Xiongwen},
  title = {Functional Heterogeneity of Hepatitis B Virus-Specific CD8+ T Cells Mediates the Clinical Outcomes of Infection},
  journal = {Frontiers in Bioscience-Landmark},
  year = {2026},
  volume = {31},
  number = {5},
  doi = {10.31083/fbl51459}
}
Kostenlos starten →